(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
2 days till quarter result
(tns 2024-05-13)
Expected move: +/- 12.79%
Live Chart Being Loaded With Signals
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases...
Stats | |
---|---|
Today's Volume | 20 724.00 |
Average Volume | 107 440 |
Market Cap | 16.71M |
EPS | $0 ( 2024-03-13 ) |
Next earnings date | ( $-1.010 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.540 |
ATR14 | $0.0390 (1.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-04 | Luthringer Remy | Buy | 100 450 | Employee Stock Option (right to buy) |
2023-10-04 | Race Geoff | Buy | 87 050 | Employee Stock Option (right to buy) |
2023-10-04 | Ahlholm Frederick W | Buy | 42 850 | Employee Stock Option (right to buy) |
2023-09-27 | Hasler Hans Peter | Buy | 12 500 | Stock Option (right to buy) |
2023-09-27 | Van Heek G Jan | Buy | 12 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
34.32 |
Last 97 transactions |
Buy: 4 702 257 | Sell: 460 450 |
Minerva Neurosciences Inc Correlation
10 Most Positive Correlations | |
---|---|
DBX | 0.956 |
RAPT | 0.947 |
GYRO | 0.917 |
MFIN | 0.912 |
UTME | 0.911 |
AKAM | 0.91 |
GASS | 0.892 |
TTWO | 0.892 |
SABR | 0.885 |
ENSC | 0.883 |
10 Most Negative Correlations | |
---|---|
ICON | -0.944 |
SCR | -0.928 |
LMNL | -0.925 |
TWNK | -0.919 |
BWC | -0.916 |
NATI | -0.915 |
SYKE | -0.912 |
ABST | -0.902 |
IMGN | -0.902 |
KELYA | -0.9 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Minerva Neurosciences Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-30 982.00 (0.00 %) |
EPS: | $-4.61 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-30 982.00 (0.00 %) |
EPS: | $-4.61 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-8 513.00 (0.00 %) |
EPS: | $-7.30 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-9.76 |
Financial Reports:
No articles found.
Minerva Neurosciences Inc
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators